CXCR7 is an Active Component of SDF-1 Signalling in Astrocytes and Schwann Cells
Overview
Affiliations
The alternative SDF-1 (stromal cell derived factor-1) receptor, CXCR7, has been suggested to act as either a scavenger of extracellular SDF-1 or a modulator of the primary SDF-1 receptor, CXCR4. CXCR7, however, also directly affects the function of various tumor-cell types. Here, we demonstrate that CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells. Cultured cortical astrocytes and peripheral nerve Schwann cells exhibit comparable total and cell-surface levels of expression of both SDF-1 receptors. Stimulation of astrocytes with SDF-1 resulted in the temporary activation of Erk1/2, Akt and PKCzeta/lambda, but not p38 and PKCalpha/beta. Schwann cells showed SDF-1-induced activation of Erk1/2, Akt and p38, but not PKCalpha/beta and PKCzeta/lambda. The respective signalling pattern remained fully inducible in astrocytes from CXCR4-deficient mice, but was abrogated following depletion of astrocytic CXCR7 by RNAi. In Schwann cells, RNAi-mediated depletion of either CXCR4 or CXCR7 silenced SDF-1 signalling. The findings of the astrocytic receptor-depletion experiments were reproduced by CXCR7 antagonist CCX754, but not by CXCR4 antagonist AMD3100, both of which abolished astrocytic SDF-1 signalling. Further underlining the functional importance of CXCR7 signalling in glial cells, we show that the mitogenic effects of SDF-1 on both glial cell types are impaired upon depleting CXCR7.
Non-neoplastic astrocytes: key players for brain tumor progression.
Catalano M, Limatola C, Trettel F Front Cell Neurosci. 2024; 17:1352130.
PMID: 38293652 PMC: 10825036. DOI: 10.3389/fncel.2023.1352130.
ACKR3-arrestin2/3 complexes reveal molecular consequences of GRK-dependent barcoding.
Chen Q, Schafer C, Mukherjee S, Gustavsson M, Agrawal P, Yao X bioRxiv. 2023; .
PMID: 37502840 PMC: 10370059. DOI: 10.1101/2023.07.18.549504.
Li X, Li Z, Li C, Fang Y, Zhang G, Yan Y J Oncol. 2022; 2022:7224840.
PMID: 36405246 PMC: 9671741. DOI: 10.1155/2022/7224840.
Jung Y, Um J, Sethi G, Ahn K Int J Mol Sci. 2022; 23(17).
PMID: 36077241 PMC: 9456465. DOI: 10.3390/ijms23179848.
Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases.
Duval V, Alayrac P, Silvestre J, Levoye A Front Endocrinol (Lausanne). 2022; 13:906586.
PMID: 35846294 PMC: 9276939. DOI: 10.3389/fendo.2022.906586.